ask="2.9500"
ask_size="200"
average_daily_volume="688103"
bid="1.3000"
bid_size="1000"
book_value="1.0670"
change="+0.1485"
change_from_200_day_moving_average="-0.8054"
change_from_50_day_moving_average="-0.0397"
change_from_52_week_high="-4.3095"
change_From_52_week_low="0.4985"
change_in_percent="+11.3359%"
close="1.4585"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.0060"
ebitda="-16.58M"
eps_estimate_current_year="-0.9200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.2800"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.4800"
high_52_weeks="5.7680"
last_trade_date="1/25/2017"
last_trade_price="1.4585"
last_trade_size="100"
last_trade_time="3:57pm"
low="1.3000"
low_52_weeks="0.9600"
market_capitalization="17.05M"
moving_average_200_day="2.2639"
moving_average_50_day="1.4982"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.3600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-35.5755%"
percent_change_from_50_day_moving_average="-2.6485%"
percent_change_from_52_week_high="-74.7139%"
percent_change_from_52_week_low="+51.9271%"
previous_close="1.3100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.2277"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.0400"
stock_exchange="NCM"
symbol="PZRX"
volume="91067"
weeks_range_52="0.9600 - 5.7680"
